Changes in adipokines following laparoscopic roux-en-Y gastric bypass surgery in chinese individuals with type 2 diabetes mellitus and BMI of 22-30 kg·m-2

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Shrestha, Chandrama ^a   He, Honghui ^a   Liu, Yiqun ^a   Zhu, Shaihong ^a   Xiong, Jing ^a   Mo, Zhaohui ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOCHEMISTRY; BODY MASS; CHINESE; CLINICAL ARTICLE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LAPAROSCOPIC SURGERY; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE CARE; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; WEIGHT REDUCTION;

EID: 84877286905     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/240971     Document Type: Article

References (31)

1. Buchwald H., Avidor Y., Braunwald E., Jensen M. D., Pories W., Fahrbach K., Schoelles K., Bariatric surgery: a systematic review and meta-analysis. Journal of the American Medical Association 2004 292 14 1724 1737 2-s2.0-5044242948 10.1001/jama.292.14.1724 (Pubitemid 39346675)
2. 2 in type 2 diabetes mellitus. Obesity Surgery 2012 22 10 1562 1567
3. DePaula A. L., Macedo A. L. V., Rassi N., Machado C. A., Schraibman V., Silva L. Q., Halpern A., Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surgical Endoscopy 2008 22 3 706 716 2-s2.0-40349100295 10.1007/s00464-007-9472-9 (Pubitemid 351341683)
4. DePaula A. L., Macedo A. L. V., Mota B. R., Schraibman V., Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surgical Endoscopy 2009 23 6 1313 1320 2-s2.0-68849124506 10.1007/s00464-008- 0156-x
5. Yamauchi T., Kamon J., Minokoshi Y., Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 2002 8 1288 1295 (Pubitemid 35373562)
6. Myeong J. Y., Gha Y. L., Chung J. J., Young H. A., Seung H. H., Jae B. K., Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor- α Diabetes 2006 55 9 2562 2570 2-s2.0-33750578279 10.2337/db05-1322 (Pubitemid 44871157)
7. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., Matsuki Y., Murakami M., Ichisaka T., Murakami H., Watanabe E., Takagi T., Akiyoshi M., Ohtsubo T., Kihara S., Yamashita S., Makishima M., Funahashi T., Yamanaka S., Hiramatsu R., Matsuzawa Y., Shimomura I., Visfatin: a protein secreted by visceral fat that Mimics the effects of insulin. Science 2005 307 5708 426 430 2-s2.0-19944433652 10.1126/science.1097243 (Pubitemid 40139988)
8. Cheng Q., Dong W., Qian L., Wu J., Peng Y., Visfatin inhibits apoptosis of pancreatic β -cell line, MIN6, via the mitogen-activated protein kinase/phosphoinositide 3-kinase pathway. Journal of Molecular Endocrinology 2011 47 1 13 21 2-s2.0-79961014704 10.1530/JME-10-0106
9. Turner R. C., Holman R. R., Matthews D., Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 1979 28 11 1086 1096 2-s2.0-0018571214 (Pubitemid 10191950)
10. World Health Organization, Obesity. Preventing and managing the global epidemic. Report of a WHO Consultation on Obesity 1998 Geneva, Switzerland World Health Organization
11. Zhou B., Wu Y., Yang J., Zhang H., Zhao L., Overweight is an independent factor for cardiovascular disease in Chinese populations. Obesity Reviews 2002 3 147 156 (Pubitemid 34815233)
12. Jia W. P., Xiang K. S., Chen L., Lu J., Wu Y. M., Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obesity Reviews 2002 3 3 157 165 2-s2.0-0035990619 10.1046/j.1467-789X.2002.00071.x (Pubitemid 34815234)
13. Ito H., Nakasuga K., Ohshima A., Maruyama T., Kaji Y., Harada M., Fukunaga M., Jingu S., Sakamoto M., Detection of cardiovascular risk factors by indices of obesity obtained from anthropometry and dual-energy X-ray absorptiometry in Japanese individuals. International Journal of Obesity 2003 27 2 232 237 2-s2.0-0037330538 10.1038/sj.ijo.802226 (Pubitemid 36255806)
14. Chang C., Wu C., Chang C., Yao W., Yang Y., Wu J., Lu F., Low body mass index but high percent body fat in Taiwanese subjects: implications of obesity cutoff. International Journal of Obesity and Related Metabolic Disorders 2003 27 253 259 (Pubitemid 36255809)
15. Lee Z., Critchley J., Ko G., Obesity and cardiovascular risk factors in Hong Kong Chinese. Obesity Reviews 2002 3 173 182 (Pubitemid 34815236)
16. Kim Y., Youn K. S., Choi H., BMI and metabolic disorders in South Korean adults: 1998 Korea National Health and Nutrition Survey. Obesity Research 2004 12 3 445 453 2-s2.0-3042668576 (Pubitemid 41132523)
17. International Obesity Task Force (on behalf of the Steering Committee), The Asia-Pacific Perspective: Redefining Obesity and Its Treatment 2002 Sydney, Australia World Health Organization Western Pacific Region
18. Huang C. K., Shabbir A., Lo C. H., Tai C. M., Chen Y. S., Houng J. Y., Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35. Obesity Surgery 2011 21 9 1344 1349
19. Hickey M. S., Pories W. J., MacDonald K. G., Cory K. A., Dohm G. L., Swanson M. S., Israel R. G., Barakat H. A., Considine R. V., Caro J. F., Houmard J. A., A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Annals of Surgery 1998 227 5 637 644 2-s2.0-0031740324 10.1097/00000658-199805000-00004 (Pubitemid 28530913)
20. Schauer P. R., Burguera B., Ikramuddin S., Cottam D., Gourash W., Hamad G., Eid G. M., Mattar S., Ramanathan R., Barinas-Mitchel E., Rao R. H., Kuller L., Kelley D., Saar M. G., Meguid M. A., Buchwald H., Effect of laparoscopic Roux-En Y gastric bypass on type 2 diabetes mellitus. Annals of Surgery 2003 238 4 467 485 2-s2.0-10744222607 (Pubitemid 38176385)
21. Cowan G. S. M., Buffington C. K., Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World Journal of Surgery 1998 22 9 987 992 2-s2.0-3543035761 10.1007/s002689900504 (Pubitemid 28374618)
22. Campos G. M., Ciovica R., Rogers S. J., Posselt A. M., Vittinghoff E., Takata M., Cello J. P., Spectrum and risk factors of complications after gastric bypass. Archives of Surgery 2007 142 10 969 975 2-s2.0-35348942827 10.1001/archsurg.142.10.969 (Pubitemid 47607605)
23. Swarbrick M. M., Stanhope K. L., Austrheim-Smith I. T., Van Loan M. D., Ali M. R., Wolfe B. M., Havel P. J., Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 2008 51 10 1901 1911 2-s2.0-51249119175 10.1007/s00125-008-1118-5
24. Hindle A. K., Edwards C., McCaffrey T., Fu S. W., Brody F., Reactivation of adiponectin expression in obese patients after bariatric surgery. Surgical Endoscopy and Other Interventional Techniques 2010 24 6 1367 1373 2-s2.0-77955665130 10.1007/s00464-009-0780-0
25. Whitson B. A., Leslie D. B., Kellogg T. A., Maddaus M. A., Buchwald H., Billington C. J., Ikramuddin S., Adipokine response in diabetics and nondiabetics following the roux-en-Y gastric bypass: a preliminary study. Journal of Surgical Research 2007 142 2 295 300 2-s2.0-34548682572 10.1016/j.jss.2007.03.036 (Pubitemid 47418830)
26. Illán-Gómez F., Gonzálvez-Ortega M., Orea-Soler I., Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obesity Surgery 2012 22 6 950 955
27. Manco M., Fernandez-Real J. M., Equitani F., Vendrell J., Mora M. E. V., Nanni G., Tondolo V., Calvani M., Ricart W., Castagneto M., Mingrone G., Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. Journal of Clinical Endocrinology and Metabolism 2007 92 2 483 490 2-s2.0-33846941566 10.1210/jc.2006-0960
28. Krzyzanowska K., Mittermayer F., Krugluger W., Kopp H. P., Schernthaner G., Increase in visfatin after weight loss induced by gastroplastic surgery. Obesity 2006 14 11 1886 1889 2-s2.0-33846313617 10.1038/oby.2006.219 (Pubitemid 46121917)
29. Haider D. G., Schindler K., Schaller G., Prager G., Wolzt M., Ludvik B., Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. Journal of Clinical Endocrinology and Metabolism 2006 91 4 1578 1581 2-s2.0-33646052892 10.1210/jc.2005-2248
30. Mingrone G., Castagneto-Gissey L., Mechanisms of early improvement / resolution of type 2 diabetes after bariatric surgery. Diabetes and Metabolism 2009 35 6 518 523 2-s2.0-75249107153 10.1016/S1262-3636(09)73459-7
31. Orea-Soler I., Illán Gómez F., Gonzálvez Ortega M., Soluble intercellular adhesion molecule-1 and C reactive protein after bariatric surgery. Endocrinología y Nutrición 2010 57 3 90 94